Cellectar Biosciences completes 1-for-30 reverse stock split effective June 24, 2025

Cellectar Biosciences, Inc.

Reverse split ratio set at 1-for-30 for common stock, par value $0.00001.
Amendment to Second Amended and Restated Certificate of Incorporation filed.
Fractional shares not issued; aggregate fractions sold by transfer agent and net proceeds distributed pro rata.

item 3.03item 5.03item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.